The FDA’s recent guidance equating “evaporated cane juice” with sugar strengthens claims of deception in food labeling suits and may prompt settlements, plaintiffs’ attorneys told Bloomberg BNA.
“The FDA’s action validates the claim, which itself is based on nutrition science, that use of the designation `ECJ’ in place of `sugar’ is misleading to consumers,” according to Maia Kats, litigation director at the Center for Science in the Public Interest in Washington, D.C.
Kats told Bloomberg BNA she would expect to see settlements where the product maker’s ECJ assertion “is conspicuous and implies that the product is healthier or more natural ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.